Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$62.39 - $113.8 $2,495 - $4,552
-40 Reduced 18.78%
173 $19,000
Q4 2021

Feb 11, 2022

BUY
$98.56 - $119.91 $17,050 - $20,744
173 Added 432.5%
213 $23,000
Q3 2021

Nov 10, 2021

BUY
$91.91 - $110.37 $3,676 - $4,414
40 New
40 $4,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track South State Corp Portfolio

Follow South State Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of South State Corp, based on Form 13F filings with the SEC.

News

Stay updated on South State Corp with notifications on news.